theophylline has been researched along with pulmicort in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.08) | 18.7374 |
| 1990's | 16 (27.12) | 18.2507 |
| 2000's | 20 (33.90) | 29.6817 |
| 2010's | 19 (32.20) | 24.3611 |
| 2020's | 1 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Erjefält, I; Persson, CG | 1 |
| Carrizo, S; Ejea, MV; García, R; Marín, JM | 1 |
| Reed, CE | 1 |
| Marney, SR | 1 |
| Price, J | 1 |
| Korppi, M; Kuikka, L; Remes, K | 1 |
| Permpikul, C; Suthamsmai, T; Wong, E; Youngchaiyud, P | 1 |
| Botey, J; Eseverri, JL; Marin, AM | 1 |
| Herceg, R; Matthys, H; Müller, S | 1 |
| Alexander, M; Boulet, LP; Côté, J; Darke, AC; Day, A; Harsanyi, Z; Kreisman, H; Rivington, RN; Small, DI | 1 |
| Reisman, JJ | 1 |
| Dahl, R; Karlström, R; Pedersen, B; Peterson, CG; Venge, P | 1 |
| Barnes, PJ; Chung, KF; Evans, DJ; O'Connor, BJ; Taylor, DA; Zetterstrom, O | 1 |
| Homer, CJ | 1 |
| Korppi, M; Reijonen, TM | 1 |
| Altieri, E; Bousquet, J; Chanez, P; Chiappara, G; Gagliardo, R; Godard, P; Térouanne, B; Vachier, I; Vic, P; Vignola, AM | 1 |
| Magnussen, H | 1 |
| Hendeles, L; Sherman, J | 1 |
| Gao, Z; He, Q; Yu, B | 1 |
| Hojo, M; Kudo, K | 1 |
| Akkaya, E; Baran, R; Ece, F; Erkan, F; Morali, T; Yilmaz, A | 1 |
| Koczorek, M | 1 |
| Calişir, HC; Ogretensoy, M; Tunçtan, B; Yurdakul, AS | 1 |
| Dahl, R; Larsen, BB; Venge, P | 1 |
| Gillissen, A; Welte, T | 1 |
| Gourgoulianis, K; Kaditis, AG; Winnie, G | 1 |
| Freihorst, J; Gappa, M; Suessmuth, S | 1 |
| Eren, A; Sipit, T; Taci, N; Yurdakul, AS | 1 |
| Averina, TK; Goriainov, AD; Il'chenko, VA; Kol'tsun, SS; Paleev, NR; Stotskaia, TV; Terpigorev, SA | 1 |
| Shah, AR; Shah, KV; Sharples, LD; Solanki, RN | 1 |
| Ukena, D | 1 |
| Braszko, JJ; Chyczewska, E; Holownia, A; Kolodziejczyk, A; Mroz, RM | 1 |
| Deng, W; Gong, Y; Li, Q; Ren, L; Sun, X; Wan, H | 1 |
| Chen, ZC; Ding, JJ; Feng, KQ; Lin, XH; Qian, HY; Wang, J | 1 |
| Ilango, K; Nageswari, AD; Rajanandh, MG | 2 |
| Matsuse, H; Tsuchida, T | 1 |
| Fraňová, S; Jošková, M; Kazimierová, I; Pecháňová, O; Šutovská, M | 1 |
| Dahlgren, D; Lennernäs, H; Roos, C; Sjögren, E | 1 |
| Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B | 1 |
| Alhnan, MA; Arafat, B; Cieszynska, M; Isreb, A; Okwuosa, TC; Pereira, BC | 1 |
| Chen, DR; Yeh, HW | 1 |
| Fattal, E; Foged, C; Kissi, EO; Leng, D; Löbmann, K; Rades, T; Thanki, K; Yang, M | 1 |
| Athari, SS; Ma, Y; Tu, Y; Yang, XH | 1 |
10 review(s) available for theophylline and pulmicort
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Asthma: recent developments in treatment.
Topics: Acute Disease; Aminophylline; Aspirin; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Calcium Channel Blockers; Cromolyn Sodium; Humans; Parasympatholytics; Pregnenediones; Rifampin; Theophylline | 1985 |
Advances in respiratory therapeutics in children.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Asthma; Bronchiolitis, Viral; Bronchodilator Agents; Budesonide; Child; Cystic Fibrosis; Hemosiderosis; Humans; Infant, Newborn; Lung Diseases; Methotrexate; Pregnenediones; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Theophylline | 1993 |
[Recent advance in inhaled corticosteroid therapy].
Topics: Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Clinical Trials as Topic; Drug Therapy, Combination; Fluticasone; Glucocorticoids; Humans; Leukotriene Antagonists; Practice Guidelines as Topic; Theophylline | 2001 |
[Do we need inhalative steroids in chronic COPD patients?].
Topics: Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Androstadienes; Anti-Inflammatory Agents; Bronchodilator Agents; Budesonide; Cholinergic Antagonists; Double-Blind Method; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Ipratropium; Multicenter Studies as Topic; Placebos; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Risk; Smoking; Theophylline; Time Factors; Triamcinolone | 2002 |
Anti-inflammatory treatment for recurrent wheezing in the first five years of life.
Topics: Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Child, Preschool; Cromolyn Sodium; Glucocorticoids; Humans; Infant; Leukotriene Antagonists; Recurrence; Respiratory Sounds; Theophylline | 2003 |
[Asthma therapy: combination of topical glucocorticosteroids and theophylline].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Theophylline | 1997 |
[Pregnancy and bronchial asthma].
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Albuterol; Asthma; Bronchodilator Agents; Budesonide; Disease Progression; Female; Glucocorticoids; Humans; Monitoring, Physiologic; Patient Education as Topic; Pregnancy; Pregnancy Complications; Respiratory Function Tests; Respiratory Physiological Phenomena; Risk; Severity of Illness Index; Smoking; Smoking Prevention; Theophylline | 2014 |
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone | 2015 |
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide | 2016 |
17 trial(s) available for theophylline and pulmicort
| Article | Year |
|---|---|
[A second drug in nonatopic asthma insufficiently controlled with beta 2-adrenergic stimulants: budesonide versus theophylline].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Asthma; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Pregnenediones; Prospective Studies; Respiratory Function Tests; Theophylline | 1990 |
A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Bronchodilator Agents; Budesonide; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Middle Aged; Pregnenediones; Spirometry; Theophylline | 1995 |
Budesonide: treatment of bronchial asthma during childhood.
Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Function Tests; Asthma; Budesonide; Child; Child, Preschool; Cromolyn Sodium; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Pregnenediones; Respiratory Function Tests; Theophylline | 1995 |
Theophylline vs. budesonide in the treatment of mild-to-moderate bronchial asthma.
Topics: Administration, Inhalation; Administration, Oral; Adult; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Budesonide; Carbachol; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Mucociliary Clearance; Peak Expiratory Flow Rate; Pregnenediones; Theophylline | 1994 |
Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pregnenediones; Pulmonary Ventilation; Theophylline | 1995 |
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Topics: Adult; Aerosols; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers; Blood Proteins; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation Mediators; Lactoferrin; Lung; Male; Middle Aged; Neurotoxins; Neutrophils; Peroxidase; Pregnenediones; Ribonuclease, Pancreatic; Ribonucleases; Smoking; Theophylline | 1996 |
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Theophylline; Vital Capacity | 1997 |
One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma.
Topics: Administration, Inhalation; Administration, Oral; Analysis of Variance; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchi; Budesonide; Chi-Square Distribution; Child, Preschool; Cromolyn Sodium; Dermatitis, Atopic; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypersensitivity; Infant; Infant, Newborn; Logistic Models; Male; Prospective Studies; Recurrence; Respiratory Sounds; Risk Factors; Theophylline; Time Factors | 1998 |
Efficacy of inhaled budesonide and oral theophylline in asthmatic subjects.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Double-Blind Method; Eosinophils; Female; Humans; Interleukin-5; Leukocyte Count; Male; Peak Expiratory Flow Rate; Theophylline; Time Factors | 2001 |
Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.
Topics: Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Phosphodiesterase Inhibitors; Respiratory Mechanics; Sulfonamides; Theophylline; Tosyl Compounds | 2002 |
Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bronchodilator Agents; Budesonide; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Long-Term Care; Lung; Male; Middle Aged; Theophylline; Treatment Outcome | 2002 |
Low-dose theophylline in childhood asthma: a placebo-controlled, double-blind study.
Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Airway Resistance; Androstadienes; Antigens, Differentiation, T-Lymphocyte; Asthma; Biomarkers; Blood Proteins; Bronchodilator Agents; Budesonide; Child; Child Welfare; Dose-Response Relationship, Drug; Double-Blind Method; Eosinophil Granule Proteins; Female; Fluticasone; Forced Expiratory Volume; Germany; Humans; Lymphocyte Count; Lymphocyte Subsets; Male; Peak Expiratory Flow Rate; Predictive Value of Tests; Respiratory Function Tests; Ribonucleases; School Health Services; T-Lymphocytes; Theophylline; Time; Treatment Outcome; Vital Capacity | 2003 |
Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
Topics: Acetates; Administration, Inhalation; Adrenergic beta-2 Receptor Antagonists; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Delayed-Action Preparations; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Quinolines; Sulfides; Theophylline; Treatment Outcome | 2003 |
Double-blind, randomised, controlled trial assessing controller medications in asthma.
Topics: Acetates; Adolescent; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Delayed-Action Preparations; Double-Blind Method; Forced Expiratory Volume; Humans; Middle Aged; Patient Selection; Quinolines; Sulfides; Theophylline | 2006 |
[Clinical efficacies of inhaled corticosteroids plus theophylline in the treatment of bronchial asthma].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aminophylline; Asthma; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Humans; Immunoglobulin E; Interleukin-4; Interleukin-5; Male; Middle Aged; Theophylline | 2013 |
Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study.
Topics: Acetates; Adult; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Middle Aged; Quinolines; Respiratory Function Tests; Sulfides; Theophylline; Tiotropium Bromide | 2014 |
Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial.
Topics: Acetates; Adolescent; Adult; Asthma; Bronchodilator Agents; Budesonide; Cyclopropanes; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Respiratory Function Tests; Sulfides; Theophylline; Tiotropium Bromide | 2015 |
32 other study(ies) available for theophylline and pulmicort
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI.
Topics: Administration, Cutaneous; Administration, Topical; Animals; Budesonide; Guinea Pigs; Inflammation; Intubation, Intratracheal; Male; Pregnenediones; Respiratory Hypersensitivity; Theophylline; Toluene 2,4-Diisocyanate; Xanthines | 1992 |
New therapeutic approaches in asthma.
Topics: Adrenergic beta-Agonists; Aerosols; Airway Obstruction; Aspirin; Asthma; Bronchi; Bronchodilator Agents; Budesonide; Calcium Channel Blockers; Cromolyn Sodium; Drug Administration Schedule; Epinephrine; Glucocorticoids; Gold; Humans; Inflammation; Mucous Membrane; Osteoporosis; Parasympatholytics; Patient Education as Topic; Prednisone; Pregnenediones; Theophylline | 1986 |
ABC of asthma. Asthma in children: treatment.
Topics: Acute Disease; Aerosols; Asthma; Beclomethasone; Budesonide; Child; Child, Preschool; Cromolyn Sodium; Humans; Infant; Prednisolone; Pregnenediones; Self Care; Theophylline | 1984 |
Preventive therapy for asthma in children; a 9-year experience in eastern Finland.
Topics: Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Cromolyn Sodium; Finland; Humans; Pregnenediones; Theophylline | 1995 |
Asthma disease management.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Glucocorticoids; Humans; Patient Care Management; Theophylline | 1997 |
Glucocorticoid receptors in bronchial epithelial cells in asthma.
Topics: Administration, Oral; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchi; Bronchitis; Bronchodilator Agents; Budesonide; Chronic Disease; Epithelial Cells; Gene Expression Regulation; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; HSP90 Heat-Shock Proteins; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Prednisone; Proteins; Receptors, Glucocorticoid; RNA, Messenger; Salmeterol Xinafoate; Theophylline | 1998 |
[Theophylline and inhaled n corticosteroids in asthma: a reliable combination].
Topics: Administration, Inhalation; Asthma; Beclomethasone; Budesonide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Forced Expiratory Volume; Humans; Theophylline; Treatment Outcome | 1998 |
Practical pharmacotherapy for pediatric asthma.
Topics: Albuterol; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Child; Glucocorticoids; Humans; Leukotrienes; Salmeterol Xinafoate; Theophylline | 2000 |
[The role of glucocorticosteroid and theophylline in asthmatic inflammation of murine model and the inhibition in NO production in lung].
Topics: Animals; Anti-Inflammatory Agents; Asthma; Budesonide; Dexamethasone; Lung; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Ovalbumin; Random Allocation; Theophylline | 1998 |
[Official therapy guidelines for the family physician. Your time table in asthma].
Topics: Administration, Topical; Adrenal Cortex Hormones; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Child; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Respiratory Therapy; Sympathomimetics; Theophylline; Time Factors | 2002 |
[Evaluation of the efficacy of inhaled glucocorticosteroids in mild bronchial asthma].
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Respiratory Mechanics; Severity of Illness Index; Spirometry; Theophylline; Vital Capacity | 2003 |
Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy.
Topics: Budesonide; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Humans; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; Sputum; Tacrolimus Binding Proteins; Theophylline | 2009 |
Low-dose theophylline restores corticosteroid responsiveness in rats with smoke-induced airway inflammation.
Topics: Adrenal Cortex Hormones; Animals; Bronchoalveolar Lavage Fluid; Budesonide; Dose-Response Relationship, Drug; Histone Deacetylase 2; Inflammation; Interleukin-8; Lung; Male; Rats; Rats, Wistar; Smoke; Smoke Inhalation Injury; Smoking; Theophylline | 2012 |
Effects of provinol and its combinations with clinically used antiasthmatics on airway defense mechanisms in experimental allergic asthma.
Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Animals; Anti-Asthmatic Agents; Antitussive Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Synergism; Drug Therapy, Combination; Guinea Pigs; Injections, Intraperitoneal; Lung; Male; Muscle, Smooth; Ovalbumin; Polyphenols; Theophylline; Tissue Culture Techniques | 2015 |
Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data.
Topics: Budesonide; Colon; Cyclosporine; Fenofibrate; Humans; Intestinal Absorption; Intestinal Mucosa; Lisdexamfetamine Dimesylate; Metoprolol; Nifedipine; Pyrimidines; Ranitidine; Rivastigmine; Sumatriptan; Terfenadine; Theophylline | 2015 |
Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.
Topics: Budesonide; Capsules; Delayed-Action Preparations; Diclofenac; Drug Compounding; Drug Liberation; Hot Temperature; Humans; Patient-Centered Care; Polymers; Povidone; Printing, Three-Dimensional; Tablets; Theophylline | 2017 |
In vitro release profiles of PLGA core-shell composite particles loaded with theophylline and budesonide.
Topics: Budesonide; Drug Liberation; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Theophylline | 2017 |
Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.
Topics: Administration, Inhalation; Bronchodilator Agents; Budesonide; Dosage Forms; Drug Combinations; Drug Therapy, Combination; Dry Powder Inhalers; Humans; Lung; Particle Size; Powders; Suspensions; Theophylline | 2019 |
Survey the effect of drug treatment on modulation of cytokines gene expression in allergic rhinitis.
Topics: Albuterol; Animals; Budesonide; Cytokines; Disease Models, Animal; Gene Expression; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Rhinitis, Allergic; Theophylline | 2023 |